Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Neuroimmunomodulation|June 28, 2021
The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis PatientsMansour Shajarian, Fereshteh Alsahebfosoul, Masoud Etemadifar
American Journal of Clinical and Experimental Immunology|January 31, 2019
Serum levels of histamine and diamine oxidase in multiple sclerosisAryan Rafiee Zadeh, Masih Falahatian, Fereshteh Alsahebfosoul
Applied Biochemistry and Biotechnology|April 13, 2018
Nanofibrous Tubular Membrane for Blood HemodialysisFarideh Mohammadi, Afsaneh Valipouri, Dariush Semnani, et al.
Annals of Indian Academy of Neurology|November 19, 2019
Interleukin 18 Polymorphisms and its serum level in Patients with Multiple SclerosisHamidreza Jahanbani-Ardakani, Fereshteh Alsahebfosoul, Masoud Etemadifar, et al.
Journal of Neuroimmunology|December 30, 2015
An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibilityNabiallah Mohammadi, Minoo Adib, Fereshteh Alsahebfosoul, et al.
Advanced Biomedical Research|March 17, 2023
Antidepressants and the Risk of Psoriasis Induction: A Case-Control StudySeyedeh-Fatemeh Sadatmadani, Amir Hossein Siadat, Fariba Iraji, et al.
Immunological Investigations|February 4, 2020
Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free TherapyMorteza Jafarinia, Fereshteh Alsahebfosoul, Hossein Salehi, et al.
Journal of Immunoassay & Immunochemistry|September 26, 2018
Serum level of interleukin 36 in patients with multiple sclerosisFereshteh Alsahebfosoul, Hamidreza Jahanbani-Ardakani, Reza Ghavimi, et al.
The International Journal of Neuroscience|December 5, 2019
Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan ProvinceMorteza Jafarinia, Erfan Sadeghi, Fereshteh Alsahebfosoul, et al.
Journal of Immunoassay & Immunochemistry|June 2, 2016
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokineShamsi Naderi, Zahra Hejazi, Mansour Shajarian, et al.
Pageof 3